PDCD1 and neoplasm: The disruption of the PD-L1 3’-UTR in an animal model facilitated the immune evasion of EG7-OVA tumor cells, with an increased PD-L1 expression in vivo, which was effectively blocked by a PD-1/PD-L1 inhibitor [62].